// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Patent foramen ovale pfo closure service evaluation remote mdt local anaesthesia and intracardiac echo ice during the covid 19 pandemic

Hussein Taqi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Atrial septal defect

N/A

Impact of patient selection on performance of an early rule out pathway for myocardial infarction from research to the real world

Anda Bularga - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Intracoronary imaging in left main stent percutaneous coronary intervention has a clear survival benefit particularly in more complex patients

Kumail Khan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparing the safety efficacy of radial versus femoral arterial access in chronic total occlusion percutaneous coronary intervention

Lloyd Tudor - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Contrast nephropathy in ppci

Simon Littlewood - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal disease

Iodixanol

Long term clinical outcomes following percutaneous coronary intervention to in stent restenosis of saphenous venous graft in acute coronary syndrome

Maria Zakai - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Impact of using the papworth haemostatic checklist on cardiac surgery patient outcomes at queen elizabeth hospital birmingham united kingdom

Tanvi Lad - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Safety and efficacy of drug coated balloons a retrospective observational study

Mohammad Ali - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Paclitaxel

A comparative study of the economics and safety of intravascular lithotripsy versus rotational atherectomy for calcium modulation in percutaneous coronary intervention a uk tertiary centre experience

Hussein Taqi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Referral to angiography for non st elevation acute coronary syndrome patients are we following the local guidelines

Ahmed Elamin - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Assessing the impact of the covid 19 pandemic on rapid access chest pain clinics a retrospective audit in glasgow

Julie Fernando - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Acute Coronary Syndromes

N/A

Utilising ddimer in diagnosing aortic dissection

Balen Abdulrahman - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence of behavioural and biological risk factors for cardiovascular disease among patients with acute coronary syndrome admited to a tertiary care hospital in sri lanka

Chintaka Wickramarachchi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Is shockwave intravascular listhotripsy for calcified coronary lesion safe and effective

Anton Labeeb - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rotashock left main bifurcation primary angioplasty with balloon pump support and intravascular image guidance

James Dargan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Developing informatics infrastructure to curate datasets using electronic health record data from five nhs hospitals for translational cardiovascular research

Amit Kaura - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Coronary wave energy to predict functional recovery in patients with ischemic left ventricular dysfunction

Matthew Ryan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic ischemic left ventricular (LV) dysfunction

Dobutamine

Drug coated balloon only angioplasty for stable angina in routine clinical practice

Ioannis Merinopoulos - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Impact of time from symptom onset on the diagnostic performance of high sensitivity cardiac troponin for type 1 myocardial infarction

Matthew Lowry - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Public reporting of outcomes after percutaneous coronary intervention is mortality the best outcome

Matthew Kelham - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Renal insufficiency

N/A

Copyright © 2026. QuantiNova All rights reserved